[Case of osteomalacia due to intravenous saccharated ferric oxide].
T, Nakaoka +3 more
openaire +1 more source
Toward Precision in Biomarker Analysis: A Novel Malondialdehyde Detection Method Based on Molecularly Imprinted Polymers. [PDF]
Nouhra M, Maalouf R, Sawan S.
europepmc +1 more source
Safety of Ferric Citrate Hydrate in Pregnant Women With Iron Deficiency Anemia, Fetuses, and Newborns: A Real-World, Observational, Post-Marketing Surveillance Study. [PDF]
Suzuki S +9 more
europepmc +1 more source
Rationale: Saccharated ferric oxide has been shown to lead to elevation of fibroblast growth factor 23, hypophosphatemia, and, consequently, osteomalacia. Moreover, mineral imbalance is often observed in patients with short-bowel syndrome to some degree. Patient concerns: A 62-year-old woman with short-bowel syndrome related with multiple resections of
openaire +1 more source
Sulfide silver autometallography to differentiate the ultrastructural localization of iron-carbohydrate complexes inside macrophages. [PDF]
Cao AM +8 more
europepmc +1 more source
Iron Dysregulation and Vascular Diseases: A Contemporary Review. [PDF]
Khandakar GI +4 more
europepmc +1 more source
Epidemiology and treatment of patients with iron deficiency and iron deficiency anemia: a study on longitudinal German health claims data. [PDF]
Manz KC +7 more
europepmc +1 more source
High-Dose Intravenous Ferric Carboxymaltose/Derisomaltose Without ESAs for Cancer-Related Anemia in Japan: A Retrospective Single-Center Cohort Study. [PDF]
Kajiura S +12 more
europepmc +1 more source
Efficacy and safety of single high-dose intravenous ferric carboxymaltose in patients undergoing hemodialysis: a multicenter, single-arm, open-label, clinical trial. [PDF]
Osawa K +14 more
europepmc +1 more source

